Skip to Content
MilliporeSigma
All Photos(3)

Key Documents

155209

Sigma-Aldrich

Pyrrolidone hydrotribromide

97%

Synonym(s):

PHT

Sign Into View Organizational & Contract Pricing

Select a Size

100 G
$99.40
500 G
$465.50

$99.40

List Price$142.00Save 30%
Web-Only Promotion

Available to ship onApril 29, 2025Details


Request a Bulk Order

Select a Size

Change View
100 G
$99.40
500 G
$465.50

About This Item

Linear Formula:
(C4H7NO)3 · HBr3
CAS Number:
Molecular Weight:
496.03
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

$99.40

List Price$142.00Save 30%
Web-Only Promotion

Available to ship onApril 29, 2025Details


Request a Bulk Order

Quality Level

assay

97%

form

solid

mp

88-90 °C (lit.)

storage temp.

2-8°C

SMILES string

Br[BrH]Br.O=C1CCCN1.O=C2CCCN2.O=C3CCCN3

InChI

1S/3C4H7NO.Br3H/c3*6-4-2-1-3-5-4;1-3-2/h3*1-3H2,(H,5,6);3H

InChI key

ITDWTSPGISAGCS-UHFFFAOYSA-N

General description

Pyrrolidone hydrotribromide has high selectivity for ketones[1].

Application

Pyrrolidone hydrotribromide was used as a brominating agent[1].

pictograms

CorrosionExclamation mark

signalword

Danger

Hazard Classifications

Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Yoshiaki Yamamoto et al.
Therapeutic drug monitoring, 39(1), 55-61 (2016-12-13)
This study investigated the pharmacokinetic interactions between topiramate (TPM) and concomitant antiepileptic drugs and evaluated the therapeutic concentration range of TPM and the effect of the achieved plasma concentration on the retention rate of TPM therapy. A total of 1217
Naoto Adachi et al.
Epilepsy & behavior : E&B, 97, 138-143 (2019-06-30)
Many studies show psychoses after some antiepileptic drug (AED) administrations (post-AED administration psychoses [PAP]). It remains uncertain about psychogenetic potential of each AED and effects of clinical state factors on PAP. We examined the relations between AED-related factors (types, generations
Karin van Bemmel et al.
Anthropology & medicine, 26(2), 177-196 (2017-10-31)
This paper presents a comparative study on conceptualizations of the poorly understood nodding syndrome (NS) in Uganda and Tanzania. NS has been constructed as a biomedical category to serve global health discourse as well as national contexts of managing the
Katrine M Johannesen et al.
Epilepsia, 60(5), 830-844 (2019-04-11)
Pathogenic variants in SCN8A have been associated with a wide spectrum of epilepsy phenotypes, ranging from benign familial infantile seizures (BFIS) to epileptic encephalopathies with variable severity. Furthermore, a few patients with intellectual disability (ID) or movement disorders without epilepsy
Manuela Contin et al.
Frontiers in pharmacology, 12, 637801-637801 (2021-03-23)
Background and Aim: Data on the clinical pharmacokinetics of cannabidiol (CBD) are scanty. We explored the effect of demographic and clinical variables on plasma concentrations of purified CBD in patients with Dravet (DS) and Lennox-Gastaut syndrome (LGS). Methods: The study

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service